|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Investments: | ||||||||||||||||||||
| Fixed income securities, held-to-maturity – at carrying value (fair value: $20,984 – 2026; $23,939 – 2025) | ||||||||||||||||||||
| Less: allowance for credit losses | ||||||||||||||||||||
| Fixed income securities, held-to-maturity, net of allowance for credit losses | ||||||||||||||||||||
| Fixed income securities, available-for-sale – at fair value (allowance for credit losses: $51,561 – 2026 and $31,287 – 2025; amortized cost: $10,382,993 – 2026 and $9,576,878 – 2025) | ||||||||||||||||||||
| Commercial mortgage loans – at carrying value (fair value: $279,076 – 2026 and $274,895 – 2025) | ||||||||||||||||||||
| Commercial mortgage loans, net of allowance for credit losses | ||||||||||||||||||||
| Equity securities – at fair value (cost: $341,199 – 2026; $370,104 – 2025) | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Alternative investments | ||||||||||||||||||||
| Other investments | ||||||||||||||||||||
| Total investments (Note 4 and 5) | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accrued investment income | ||||||||||||||||||||
| Premiums receivable | ||||||||||||||||||||
| Less: allowance for credit losses (Note 6) | ||||||||||||||||||||
| Premiums receivable, net of allowance for credit losses | ||||||||||||||||||||
| Reinsurance recoverable | ||||||||||||||||||||
| Less: allowance for credit losses (Note 7) | ||||||||||||||||||||
| Reinsurance recoverable, net of allowance for credit losses | ||||||||||||||||||||
| Prepaid reinsurance premiums | ||||||||||||||||||||
| Current federal income tax | ||||||||||||||||||||
| Deferred federal income tax | ||||||||||||||||||||
| Property and equipment – at cost, net of accumulated depreciation and amortization of: $317,147 – 2026; $297,211 – 2025 | ||||||||||||||||||||
| Deferred policy acquisition costs | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Reserve for loss and loss expense (Note 8) | ||||||||||||||||||||
| Unearned premiums | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Current federal income tax | ||||||||||||||||||||
| Accrued salaries and benefits | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ Equity: | ||||||||||||||||||||
| Preferred stock | ||||||||||||||||||||
| Common stock | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) (Note 11) | ||||||||||||||||||||
| Treasury stock – at cost (shares: 47,288,070 – 2026; 45,930,091 – 2025) | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
| Preferred stock, Par or Stated Value (in dollars per share) | ||||||||||||||||||||
| Total preferred stock, Par or Stated Value (in dollars per share) | ||||||||||||||||||||
Loading...